CurvaFix, developer of devices to repair fractures in curved bones, has been awarded a Technology Breakthrough Designation for General Orthopedic Trauma Products with Premier Inc.

Premier provides Breakthrough Technology designations to innovations that show a significant advantage regarding patient safety, clinical outcomes, and operational efficiencies.

The CurvaFix system, an intramedullary (IM) implant that follows natural pelvis curvature, was built to expand surgical options in challenging fracture scenarios. This includes curved or narrow pelvic corridors, pathological bone, intersection fixation pathways, and indwelling and adjacent hardware.

“Being awarded a Premier Technology Breakthrough Designation represents a major step forward for CurvaFix, as Premier’s extensive GPO network offers unmatched national scale and reach, enabling more hospitals and health systems to adopt our innovative fixation technology,” said Mark Foster, CEO of CurvaFix. “This expanded market access positions us well to deliver clinical and economic value, thereby supporting providers with cost-effective solutions while helping patients return to mobility and quality of life after they have suffered pelvic fractures.”

The company said clinical experience has shown its technology offers strong, stable fixation that follows and fills the natural curvature of each patient’s anatomy. The approach can reduce pain, support earlier mobility, and improve recovery compared to conventional straight implants.

“Premier’s network includes thousands of hospitals and health systems across the U.S.,” continued Foster. “By being a Premier vendor, we can deliver our technology to care teams on a national scale, helping providers control costs while bringing patients advanced solutions that improve their recovery journey significantly.”

In September, CurvaFix earned U.S. Food and Drug Administration (FDA) clearance for its next-generation low-profile system, a percutaneous solution for pelvic fracture fixation.